We are Elrha, a force for change in the humanitarian community. The research and innovation we support equips the humanitarian community with the knowledge of what works, so people affected by crises get the right help when they need it most.
Our purpose is clear: to empower the humanitarian community to improve humanitarian response. We make this happen by supporting and championing the outcomes of robust research and proven innovations.
We empower the humanitarian community. Find out how we can support you...

The rising toll of the COVID-19 pandemic and concerns about emerging SARS-CoV-2 variants have underscored the urgency of a rapid, equitable and inclusive rollout of vaccines against COVID-19. However, as the world grapples with supply challenges and inequitable vaccine access on local and global scales, marginalized groups, particularly refugees, internally displaced persons and stateless persons, will face a double burden of access, even within countries that are themselves marginalized on the global stage.

This paper calls for a coordinated, comprehensive and global approach to vaccine access – science and need, not wealth, nationality or legal status, should guide vaccine allocation and prioritisation.

View publication

Subscribe to our newsletters....

Subscribe
 
Elrha © 2018 - 2022 Elrha is a registered charity in England and Wales (1177110). KEEP IN TOUCH Want to stay up to date with our latest updates? Sign up to our newsletters
Elrha
Elrha Please upgrade your browser

You are seeing this because you are using a browser that is not supported. The Elrha website is built using modern technology and standards. We recommend upgrading your browser with one of the following to properly view our website:

Windows Mac

Please note that this is not an exhaustive list of browsers. We also do not intend to recommend a particular manufacturer's browser over another's; only to suggest upgrading to a browser version that is compliant with current standards to give you the best and most secure browsing experience.